CRISPR Systems for COVID-19 Diagnosis.

Published on Jan 27, 2021in ACS Sensors7.333
· DOI :10.1021/ACSSENSORS.0C02312
Hossein Rahimi2
Estimated H-index: 2
(Zanjan University of Medical Sciences),
Marziyeh Salehiabar10
Estimated H-index: 10
(Tabriz University of Medical Sciences)
+ 10 AuthorsJoão Conde33
Estimated H-index: 33
(NOVA: Universidade Nova de Lisboa)
Sources
Abstract
The emergence of the new coronavirus 2019 (COVID-19) was first seen in December 2019, which has spread rapidly and become a global pandemic. The number of cases of COVID-19 and its associated mortality have raised serious concerns worldwide. Early diagnosis of viral infection undoubtedly allows rapid intervention, disease management, and substantial control of the rapid spread of the disease. Currently, the standard approach for COVID-19 diagnosis globally is the RT-qPCR test; however, the limited access to kits and associated reagents, the need for specialized lab equipment, and the need for highly skilled personnel has led to a detection slowdown. Recently, the development of clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostic systems has reshaped molecular diagnosis. The benefits of the CRISPR system such as speed, precision, specificity, strength, efficiency, and versatility have inspired researchers to develop CRISPR-based diagnostic and therapeutic methods. With the global COVID-19 outbreak, different groups have begun to design and develop diagnostic and therapeutic programs based on the efficient CRISPR system. CRISPR-based COVID-19 diagnostic systems have advantages such as a high detection speed (i.e., 30 min from raw sample to reach a result), high sensitivity and precision, portability, and no need for specialized laboratory equipment. Here, we review contemporary studies on the detection of COVID-19 based on the CRISPR system.
📖 Papers frequently viewed together
5 Citations
5 Citations
1 Citations
References107
Newest
#1Jennifer N. Rauch (UCSB: University of California, Santa Barbara)H-Index: 21
#2Eric Valois (UCSB: University of California, Santa Barbara)H-Index: 5
Last. Maxwell Z. Wilson (UCSB: University of California, Santa Barbara)H-Index: 11
view all 13 authors...
The COVID-19 pandemic has created massive demand for widespread, distributed tools for detecting SARS-CoV-2 genetic material. The hurdles to scalable testing include reagent and instrument accessibility, availability of highly trained personnel, and large upfront investment. Here we showcase an orthogonal pipeline we call CREST (Cas13-based, Rugged, Equitable, Scalable Testing) that addresses some of these hurdles. Specifically, CREST pairs commonplace and reliable biochemical methods (PCR) with...
10 CitationsSource
#1Parinaz FozouniH-Index: 8
#2Sungmin Son (University of California, Berkeley)H-Index: 12
Last. Melanie OttH-Index: 64
view all 32 authors...
Summary The December 2019 outbreak of a novel respiratory virus, SARS-CoV-2, has become an ongoing global pandemic due in part to the challenge of identifying symptomatic, asymptomatic, and pre-symptomatic carriers of the virus. CRISPR diagnostics can augment gold-standard PCR-based testing if they can be made rapid, portable, and accurate. Here, we report the development of an amplification-free CRISPR-Cas13a assay for direct detection of SARS-CoV-2 from nasal swab RNA that can be read with a m...
33 CitationsSource
#1Andrea Bonini (UniPi: University of Pisa)H-Index: 7
#2Noemi Poma (UniPi: University of Pisa)H-Index: 6
Last. Fabio Di Francesco (UniPi: University of Pisa)H-Index: 17
view all 8 authors...
Abstract A main challenge in the development of biosensing devices for the identification and quantification of nucleic acids is to avoid the amplification of the genetic material from the sample by polymerase chain reaction (PCR), which is at present necessary to enhance sensitivity and selectivity of assays. PCR has undoubtedly revolutionized genetic analyses, but it requires careful purification procedures that are not easily implemented in point of care (POC) devices. In recent years, a new ...
6 CitationsSource
#1Harikrishnan Jayamohan (UofU: University of Utah)H-Index: 8
#2Christopher J. Lambert (UofU: University of Utah)H-Index: 6
Last. Bruce K. Gale (UofU: University of Utah)H-Index: 37
view all 10 authors...
The unprecedented global pandemic known as SARS-CoV-2 has exercised to its limits nearly all aspects of modern viral diagnostics. In doing so, it has illuminated both the advantages and limitations of current technologies. Tremendous effort has been put forth to expand our capacity to diagnose this deadly virus. In this work, we put forth key observations in the functionality of current methods for SARS-CoV-2 diagnostic testing. These methods include nucleic acid amplification-, CRISPR-, sequenc...
26 CitationsSource
#1Ritika GuptaH-Index: 5
#2Poonam SagarH-Index: 1
Last. Nitin Kumar SinghalH-Index: 14
view all 7 authors...
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as pandemic is proven to be a severe medical burden and affected - socio-economic activities globally. Proven transmission of this virus occurs through airborne droplets from infected person. Recent upsurge in the number of infected individuals has already crossed the number of intensive care units available to the patients. These extraordinary circumstances has elicited the need of development of diagnostic too...
2 CitationsSource
#1Jeong Moon (KAIST)H-Index: 7
#2Hyung Jun Kwon (Korea Research Institute of Bioscience and Biotechnology)H-Index: 4
Last. Taejoon KangH-Index: 23
view all 11 authors...
Viruses have been a continuous threat to human beings. The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a pandemic that is still ongoing worldwide. Previous pandemic influenza A virus (pH1N1) might be re-emerging through a drug-resistant mutation. We report a colorimetric viral detection method based on the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 endonuclease dead (dCas9) system. In this me...
2 CitationsSource
#1Jon Arizti-Sanz (MIT: Massachusetts Institute of Technology)H-Index: 2
#2Catherine A. Freije (MIT: Massachusetts Institute of Technology)H-Index: 15
Last. Cameron Myhrvold (MIT: Massachusetts Institute of Technology)H-Index: 19
view all 23 authors...
The COVID-19 pandemic has highlighted that new diagnostic technologies are essential for controlling disease transmission. Here, we develop SHINE (Streamlined Highlighting of Infections to Navigate Epidemics), a sensitive and specific diagnostic tool that can detect SARS-CoV-2 RNA from unextracted samples. We identify the optimal conditions to allow RPA-based amplification and Cas13-based detection to occur in a single step, simplifying assay preparation and reducing run-time. We improve HUDSON ...
21 CitationsSource
Infectious diseases are one of the most intimidating threats to human race, responsible for an immense burden of disabilities and deaths. Rapid diagnosis and treatment of infectious diseases offers a better understanding of their pathogenesis. According to the World Health Organization, the ideal approach for detecting foreign pathogens should be rapid, specific, sensitive, instrument-free, and cost-effective. Nucleic acid pathogen detection methods, typically PCR, have numerous limitations, suc...
5 CitationsSource
#1Ashwin Ramachandran (Stanford University)H-Index: 7
#2Diego A. Huyke (Stanford University)H-Index: 2
Last. Juan G. Santiago (Stanford University)H-Index: 74
view all 8 authors...
The rapid spread of COVID-19 across the world has revealed major gaps in our ability to respond to new virulent pathogens. Rapid, accurate, and easily configurable molecular diagnostic tests are imperative to prevent global spread of new diseases. CRISPR-based diagnostic approaches are proving to be useful as field-deployable solutions. In one basic form of this assay, the CRISPR-Cas12 enzyme complexes with a synthetic guide RNA (gRNA). This complex becomes activated only when it specifically bi...
23 CitationsSource
#1Weiren Huang (SZU: Shenzhen University)H-Index: 21
#1Weiren Huang (SZU: Shenzhen University)H-Index: 2
Last. Jin Wang (SHNU: Shanghai Normal University)H-Index: 2
view all 44 authors...
Abstract Background Real-time reverse transcription-PCR (rRT-PCR) has been the most effective and widely implemented diagnostic technology since the beginning of the COVID-19 pandemic. However, fuzzy rRT-PCR readouts with high Ct values are frequently encountered, resulting in uncertainty in diagnosis. Methods A Specific Enhancer for PCR-amplified Nucleic Acid (SENA) was developed based on the Cas12a trans-cleavage activity, which is specifically triggered by the rRT-PCR amplicons of the SARS-Co...
7 CitationsSource
Cited By5
Newest
#1Xiaobin Dong (Huada: Beijing University of Chemical Technology)H-Index: 2
#2Luyao Liu (Huada: Beijing University of Chemical Technology)H-Index: 2
Last. Xianbo Qiu (Huada: Beijing University of Chemical Technology)H-Index: 17
view all 0 authors...
PCR has been widely used in different fields including molecular biology, pathogen detection, medical diagnosis, food detection and etc. However, the difficulty of promoting PCR in on-site point-of-care testing reflects on challenges relative to its speed, convenience, complexity, and even cost. With the emerging state-of-art of microfluidics, rapid PCR can be achieved with more flexible ways in micro-reactors. PCR plays a critical role in the detection of SARS-CoV-2. Under this special backgrou...
Source
Last. Ajeet KaushikH-Index: 51
view all 0 authors...
The emergence of new SARS-CoV-2 variants made the COVID-19 infection pandemic or endemic- or both more severe and life-threatening due to ease of transmission, rapid infection, high mortality, and capacity to neutralize the therapeutic ability of developed vaccines. These consequences raises questions on established COVID-19 infection management strategies based on nano-assisted approaches, including rapid diagnostics, therapeutics, and efficient tarping and virus eradication through stimuli-ass...
Source
#1Sneha Gulati (Institute of Genomics and Integrative Biology)H-Index: 1
#2Souvik Maiti (Institute of Genomics and Integrative Biology)H-Index: 44
Last. Debojyoti Chakraborty (Institute of Genomics and Integrative Biology)H-Index: 11
view all 4 authors...
Next-generation sequencing (NGS) has identified disease hallmarks and catalogued a vast reservoir of genetic information from humans and other species. Precise nucleotide-interrogation properties of clustered regularly interspaced short palindromic repeats (CRISPR) proteins have been harnessed to rapidly identify DNA-RNA signatures for diverse applications, bypassing the cost and turnaround times associated with diagnostic NGS.
Source
#1Hani Nasser Abdelhamid (Assiut University)H-Index: 40
#2Gamal Badr (Assiut University)H-Index: 32
A sensitive method for diagnosing coronavirus disease 2019 (COVID-19) is highly required to fight the current and future global health threats due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2). However, most of the current methods exhibited high false‐negative rates, resulting in patient misdiagnosis and impeding early treatment. Nanoparticles show promising performance and great potential to serve as a platform for diagnosing viral infection in a short time and with high sensi...
Source
#1Julia Martín (University of Seville)H-Index: 25
#2Noelia Tena (University of Seville)H-Index: 14
Last. Agustin G. Asuero (University of Seville)H-Index: 25
view all 3 authors...
Abstract Since December 2019, we have been in the battlefield with a new threat to the humanity known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review, we describe the four main methods used for diagnosis, screening and/or surveillance of SARS-CoV-2: Real-time reverse transcription polymerase chain reaction (RT-PCR); chest computed tomography (CT); and different complementary alternatives developed in order to obtain rapid results, antigen and antibody detection. A...
Source
#2Sergey BrezginH-Index: 5
Last. Vladimir ChulanovH-Index: 14
view all 7 authors...
Infectious diseases are a global health problem affecting billions of people. Developing rapid and sensitive diagnostic tools is key for successful patient management and curbing disease spread. Currently available diagnostics are very specific and sensitive but time-consuming and require expensive laboratory settings and well-trained personnel; thus, they are not available in resource-limited areas, for the purposes of large-scale screenings and in case of outbreaks and epidemics. Developing ne...
Source
#1Sanaz Nargesi (Mazandaran University of Medical Sciences)H-Index: 1
#2Saeed Kaboli (Zanjan University of Medical Sciences)H-Index: 5
Last. Mohammad Taghi Hedayati (Mazandaran University of Medical Sciences)H-Index: 30
view all 7 authors...
Manipulating fungal genomes is an important tool to understand the function of target genes, pathobiology of fungal infections, virulence potential, and pathogenicity of medically important fungi, and to develop novel diagnostics and therapeutic targets. Here, we provide an overview of recent advances in genetic manipulation techniques used in the field of medical mycology. Fungi use several strategies to cope with stress and adapt themselves against environmental effectors. For instance, mutati...
Source
#1Hamid Rashidzadeh (Zanjan University of Medical Sciences)H-Index: 5
#2Hossein Danafar (Zanjan University of Medical Sciences)H-Index: 30
Last. Mehdi Mirsaeidi (UM: University of Miami)H-Index: 32
view all 19 authors...
Coronavirus 2019 (COVID-19), as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine has been approved yet for this pandemic disease. Cutting-edge tools, especially nanotechnology, should be strongly considered to tackle this virus. This review aims to propose several strategies to design and fabricate effective diagnostic and therapeutic agents against COVID-19 by the aid of nanotechnology. Polymeric, i...
Source